Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration
2008

Initial Severity and Antidepressant Benefits: A Meta-Analysis

Sample size: 5133 publication Evidence: moderate

Author Information

Author(s): Irving Kirsch, Brett J. Deacon, Tania B. Huedo-Medina, Alan Scoboria, Thomas J. Moore

Primary Institution: Department of Psychology, University of Hull

Hypothesis

Does the initial severity of depression affect the efficacy of antidepressants?

Conclusion

Antidepressant efficacy increases with baseline severity, but the differences are small even for severely depressed patients.

Supporting Evidence

  • Antidepressants showed a mean drug–placebo difference of 1.80 points on the HRSD.
  • The efficacy of antidepressants was clinically significant only for patients with very severe depression.
  • Placebo responses decreased as initial severity increased, affecting the perceived efficacy of antidepressants.

Takeaway

The more depressed someone is, the better antidepressants seem to work compared to a sugar pill, but they still don't work that well overall.

Methodology

Meta-analysis of clinical trials submitted to the FDA for four new-generation antidepressants.

Potential Biases

Potential reporting bias was minimized by including both published and unpublished trials.

Limitations

The study primarily included data from trials with very severely depressed patients, limiting generalizability.

Participant Demographics

The study involved adult patients diagnosed with unipolar major depressive disorder.

Statistical Information

P-Value

1.80

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050045

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication